Thank you very much for your question.
I think what I'll indicate is the actual context of my discussions on the ministerial level with our isotope-producing counterparts.
What I have done is stress with them the importance of the supply side and the demand side of the issue. As I have indicated, we've had two international calls on the matter. This morning I participated in the first discussion of the high-level group for which Canada is the chair and is driving the agenda.
This also underlines that both major producers and consumers have recognized the need to work internationally on action across a whole range of issues. One of the issues is coordinating reactor schedules to see whether there is increased capacity at reactors. We've done that, and the countries have reported back that they can increase, can ramp up.
The second aspect, though, is equally important. That is to make sure that the medical practitioners and the medical community have timely, cogent information, so that they're able to manage the supply they do have, so that we avoid as best we can the situation that Canadians are in the dark and are worried and wondering whether they're going to have a diagnostic procedure done. Right now, the information gap is unfortunately too wide, and this international effort is about bridging that gap and having more information in the hands of the medical practitioners, so that they can communicate to the Canadian public what diagnostic procedures are available and when.
